Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026)
Varex Imaging (VREX) reported Cash from Financing Activities of -$29.3 million for Q2 2026, down 4085.71% year-over-year from $735125.4 in Q2 2025, and down 1731.25% quarter-over-quarter from -$1.6 million in Q1 2026.
Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Cash from Financing Activities data on file, last reported at -$29.3 million in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$29.3 million, down 4085.71% year-over-year; the trailing twelve-month figure through Apr 2026 was -$231.0 million (down 286.44% YoY), and the FY2025 annual result was -$75.9 million, down 2200.0% from the prior year.
- Cash from Financing Activities eased to -$29.3 million in Q2 2026 per VREX's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $124.9 million in Q1 2025 and troughed at -$201.2 million in Q3 2025.
- A 5-year average of -$8.2 million and a median of -$700000.0 in 2023 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 7447.06% in 2025 and fell as far as 18190.91% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$400000.0 in 2022, then tumbled by 325.0% to -$1.7 million in 2023, then soared by 147.06% to $800000.0 in 2024, then soared by 37.5% to $1.1 million in 2025, then sank by 2763.64% to -$29.3 million in 2026.
- Business Quant data shows VREX's Cash from Financing Activities at -$29.3 million in Q2 2026, -$1.6 million in Q1 2026, and $1.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Varex Imaging | 461.58 Mn | 387.18 Mn | 72.60 Mn | -29.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -29.30 Mn |
| Apr 3, 2026 | -29.30 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Apr 4, 2025 | -700,000.00 |
| Apr 4, 2025 | -700,000.00 |
| Jan 3, 2025 | 124.90 Mn |
| Jan 3, 2025 | 124.90 Mn |
| Sep 27, 2024 | 800,000.00 |
| Sep 27, 2024 | 800,000.00 |
| Jun 28, 2024 | -1.10 Mn |
| Jun 28, 2024 | -1.10 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Dec 29, 2023 | -1.70 Mn |
| Dec 29, 2023 | -1.70 Mn |